In the univariate analysis, therapeutic regimens, including the use of renin-angiotensin-aldosterone system (RAAS) blockers and insulin medication, as well as clinical conditions (hyperlipidemia, obesity, smoking, and family history of diabetes), had no significant effect on the type or number of glomerular macrophages. Here, INS is linked to obesity disorder.